Literature DB >> 26587935

Incidental Thyroid Nodules on CT or MRI: Discordance Between What We Report and What Receives Workup.

Teerath P Tanpitukpongse1, Allen T Grady1, Julie A Sosa2, James D Eastwood1, Kingshuk R Choudhury1, Jenny K Hoang1,3.   

Abstract

OBJECTIVE: The objective of this study was to determine the proportion of incidental thyroid nodules (ITNs) reported on CT or MRI that receive additional workup and the factors that influence workup. A secondary aim was to evaluate the effect of the American College of Radiology (ACR) white paper recommendations for reporting of ITNs.
MATERIALS AND METHODS: We retrospectively reviewed patients with ITNs reported on CT or MRI studies over 12 months. We identified patients with ITNs that underwent workup and the factors associated with workup. The ACR white paper recommendations were retrospectively applied to estimate how their use would have changed the number of nodules reported in the impression section of radiology reports and the number of cancers diagnosed. The recommendations are based on suspicious imaging features, patient age, and nodule size.
RESULTS: A total of 375 patients had ITNs reported. For 138 of these patients (37%), ITNs were reported by radiologists in the impression section of their reports; 26 patients (19%) received workup. Patients with ITNs reported in the impression section were 14 times more likely to undergo workup than were patients with ITNs reported only in the findings section of the radiology report. On multivariate analysis, the only factors associated with workup were younger patient age and larger nodule size (p ≤ 0.002). The ACR recommendations resulted in a 54% reduction in the number of ITNs reported in the impression section and one missed papillary cancer (TNM classification T1bN0M0).
CONCLUSION: Only one in five patients with ITNs reported in the impression section of CT or MRI reports underwent additional workup, and this decision was influenced by younger patient age and larger nodule size. These factors are components of the ACR recommendations, which have the potential to reduce the number of reported ITNs and improve the standardization of radiology reporting.

Entities:  

Keywords:  CT; MRI; incidental; nodule; thyroid

Mesh:

Year:  2015        PMID: 26587935     DOI: 10.2214/AJR.15.14929

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Incidental findings in the thyroid gland on computed tomography images of the oral and maxillofacial region.

Authors:  Abdullah Khasawneh; Yohei Takeshita; Miki Hisatomi; Toshiyuki Kawazu; Mariko Fujita; Shunsuke Okada; Yuri Namba; Yudai Shimizu; Yoshinobu Yanagi; Junichi Asaumi
Journal:  Oncol Lett       Date:  2020-01-13       Impact factor: 2.967

2.  Incidental finding of papillary thyroid carcinoma on CT examination of mandibular lesion: Case report.

Authors:  Irfan Sugianto; Yoshinobu Yanagi; Hidenobu Konouchi; Miki Hisatomi; Shunsuke Okada; Babatunde O Bamgbose; Junichi Asaumi
Journal:  Mol Clin Oncol       Date:  2017-11-02

3.  The fate of radiology report recommendations at a pediatric medical center.

Authors:  Bonmyong Lee; Hansel J Otero; Matthew T Whitehead
Journal:  Pediatr Radiol       Date:  2017-08-29

4.  Incidental thyroid nodules on thoracic contrast-enhanced computed tomography in clinical practice during a 10-year period: Characteristics, clinical outcomes, and factors contributing to further evaluation.

Authors:  Ju Yong Park; Kyung Hee Lee; Soon Gu Cho; Yeo Ju Kim; Ha Young Lee; In Ki Hong; Jun Ho Kim
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

5.  Quantitative Assessment of Thyroid Nodules Using Dual-Energy Computed Tomography: Iodine Concentration Measurement and Multiparametric Texture Analysis for Differentiating between Malignant and Benign Lesions.

Authors:  Hayato Tomita; Hirofumi Kuno; Kotaro Sekiya; Katharina Otani; Osamu Sakai; Baojun Li; Takashi Hiyama; Keiichi Nomura; Hidefumi Mimura; Tatsushi Kobayashi
Journal:  Int J Endocrinol       Date:  2020-03-18       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.